« go back

Cancer Research UK Pioneer Awards

By Andy Boyce

Cancer Research UK Pioneer Award

From the Cancer Research UK website

What is the Pioneer Award?

Our Pioneer Award offers £200,000 to encourage innovative ideas from any discipline that could be groundbreaking in tackling cancer. The Award backs higher risk, truly novel ideas that have the potential for high reward in understanding, preventing, diagnosing or treating cancer. Funding for your idea up to £200,000 over two years Judged by a diverse committee of innovators Awarded through our fast, concise application process

Who can apply?

We welcome applications from individuals and teams, from any discipline, regardless of background or vocation. You don't need a stunning track record or vast quantities of evidence to back you up (although any you do have will be taken into account) – we're interested in your idea's potential.

How to apply It's easy to apply!

Start with a two page proposal to summarise your idea, then our world-class panel will judge your idea anonymously. The panel is extremely diverse and represents innovation and entrepreneurship from a broad range of disciplines. If your idea impresses them, you'll be invited to pitch. The deadline For your revolutionary idea to be considered in the next funding round of the Pioneer Award, submit your brief proposal online by 12 April 2016. If you're successful, you'll be invited to pitch to the panel in July. Before you apply, you can find out more about how to apply in our scheme guidelines (PDF), and find out more about what we will and won’t fund in our frequently asked questions.

Subscribe to our updates

Subscribe to our newsletters
Follow us on twitter

Join us on LinkedIn

Keep up to date with the latest agri-food and biosciences news, events, funding opportunities and more.

Read our latest newsletter

Subscribe to our RSS feed

Subscribe to our SynBio SIG RSS news feed by adding this link to your favourite news reader.

Send us your news

Got a great news story, event or funding opportunity relevant to the synthetic biology community?

Email us: